ALK and neoplasm: In the third univariate-screening step, ALK, ECOG (missing, 0, 1 versus 2 or more), LMET on CL, sex, SGOT, SGPT, number of metastatic sites (0–3 versus 4 or more) on Vc, and primary tumor type on Km were found to be significant (p < 0.005).